Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation.

[1]  Ryan M Spengler,et al.  Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma , 2021, Oncotarget.

[2]  K. Chatfield-Reed,et al.  cfDNA detection for HPV+ squamous cell carcinomas. , 2021, Oral oncology.

[3]  E. Mendez,et al.  Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311). , 2020 .

[4]  Ash A. Alizadeh,et al.  A mathematical model of ctDNA shedding predicts tumor detection size , 2020, Science Advances.

[5]  G. Gupta,et al.  Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K. Fung,et al.  Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. , 2019, The Lancet. Oncology.

[7]  D. Fried,et al.  Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  David L. Marron,et al.  Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer , 2019, Clinical Cancer Research.

[9]  A. Viale,et al.  Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy. , 2019, JCO precision oncology.

[10]  C. Paweletz,et al.  Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  Lihong Qi,et al.  Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. , 2017, The Lancet. Oncology.

[12]  Q. Wei,et al.  Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer , 2015, Cancer.

[13]  J. Califano,et al.  Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. , 2014, JAMA otolaryngology-- head & neck surgery.

[14]  A. Garden,et al.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.